Organization

University of Arkansas for Medical Sciences Winthrop P. Rockefeller Institute

2 abstracts

Abstract
Curability of multiple myeloma (MM) based on relative survival rate (RSR) in patients (pts) treated on earlier total therapy (TT) protocols.
Org: University of Arkansas for Medical Sciences (UAMS), Jordan University of Science and Technology, University of Arkansas for Medical Sciences Winthrop P. Rockefeller Institute, Myeloma Center, The University of Arkansas for Medical Sciences/Arkansas Children’s Hospital,
Abstract
Three years (yrs) maintenance with bortezomib, lenalidomide, and dexamethasone (RVD) in multiple myeloma (MM): Results of Total Therapy (TT) IIIB.
Org: University of Arkansas for Medical Sciences (UAMS), Jordan University of Science and Technology, University of Arkansas for Medical Sciences Winthrop P. Rockefeller Institute, Myeloma Center, The University of Arkansas for Medical Sciences/Arkansas Children’s Hospital,